New Dawn At Novartis As Narasimhan Demands Breakthroughs

 
• By Kevin Grogan

Vas Narasimhan says it’s not enough to develop drugs that are first- or best-in-class, they have to be transformational in the benefits they offer patients and society at large. CAR-T therapy Kymriah fits the bill.

Torch
All yours: Joe Jimenez has passed the torch to Vas Narasimhan • Source: Shutterstock

More from Business

More from Scrip